A SINGLE CENTER RETROSPECTIVE ANALYSIS OF EFFICACY AND SAFETY BETWEEN LOW-DOSE VERSUS HIGH-DOSE RITUXIMAB AS REMISSION INDUCTION THERAPY IN JAPANESE PATIENTS WITH ANCA-ASSOCIATED VASCULITIS

被引：0
|
作者：
Hirose, Kei [1 ]
Hirata, Manami [1 ]
Yamamura, Yuriko [1 ]
Ueno, Akiko [1 ]
Yamamura, Masahiro [1 ]
机构：
[1] Okayama Saiseikai Gen Hosp, Ctr Rheumatol, Okayama, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.4450
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0590
引用
收藏
页码：1756 / 1756
页数：1
相关论文
共 50 条
  • [31] A RANDOMIZED, CONTROLLED TRIAL OF RITUXIMAB VERSUS AZATHIOPRINE AFTER INDUCTION OF REMISSION WITH RITUXIMAB FOR PATIENTS WITH ANCA-ASSOCIATED VASCULITIS AND RELAPSING DISEASE
    Smith, Rona
    Jayne, David
    Merkel, Peter
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 2185 - 2185
  • [32] A Randomized, Controlled Trial of Rituximab versus Azathioprine After Induction of Remission with Rituximab for Patients with ANCA-associated Vasculitis and Relapsing Disease
    Smith, Rona
    Jayne, David
    Merkel, Peter
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [33] INDUCTION THERAPY WITH RITUXIMAB ENABLES SUSTAINED REMISSION IN ELDERLY PATIENTS WITH RELAPSED ANCA-ASSOCIATED VASCULITIS: A RETROSPECTIVE ANALYSIS FROM J-CANVAS, A JAPANESE MULTICENTRE-COHORT
    Kidoguchi, G.
    Yoshida, Y.
    Watanabe, H.
    Sugimoto, T.
    Mokuda, S.
    Kida, T.
    Yajima, N.
    Omura, S.
    Nakagomi, D.
    Abe, Y.
    Kadoya, M.
    Takizawa, N.
    Nomura, A.
    Yuji, K.
    Kondo, N.
    Yasuhiko, Y.
    Yanagida, T.
    Endo, K.
    Matsui, K.
    Takeuchi, T.
    Ichinose, K.
    Kato, M.
    Yanai, R.
    Matsuo, Y.
    Shimojima, Y.
    Nishioka, R.
    Okazaki, R.
    Takata, T.
    Ito, T.
    Moriyama, M.
    Takatani, A.
    Miyawaki, Y.
    Ito-Ihara, T.
    Kawaguchi, T.
    Kawahito, Y.
    Hirata, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1603 - 1604
  • [34] Optimal dose of intravenous cyclophosphamide during remission induction therapy in ANCA-associated vasculitis: A retrospective cohort study of J-CANVAS
    Sofue, Hideaki
    Kida, Takashi
    Hirano, Aiko
    Omura, Satoshi
    Kadoya, Masatoshi
    Nakagomi, Daiki
    Abe, Yoshiyuki
    Takizawa, Naoho
    Nomura, Atsushi
    Kukida, Yuji
    Kondo, Naoya
    Yamano, Yasuhiko
    Yanagida, Takuya
    Endo, Koji
    Hirata, Shintaro
    Matsui, Kiyoshi
    Takeuchi, Tohru
    Ichinose, Kunihiro
    Kato, Masaru
    Yanai, Ryo
    Matsuo, Yusuke
    Shimojima, Yasuhiro
    Nishioka, Ryo
    Okazaki, Ryota
    Takata, Tomoaki
    Ito, Takafumi
    Moriyama, Mayuko
    Takatani, Ayuko
    Miyawaki, Yoshia
    Ito-Ihara, Toshiko
    Yajima, Nobuyuki
    Kawaguchi, Takashi
    Fujioka, Kazuki
    Fujii, Wataru
    Seno, Takahiro
    Wada, Makoto
    Kohno, Masataka
    Kawahito, Yutaka
    MODERN RHEUMATOLOGY, 2023, 34 (04) : 767 - 774
  • [35] Comparative efficacy and safety of low-dose and high-dose cyclophosphamide as induction therapy for lupus nephritis: a network meta-analysis
    Bae, S-C
    Lee, Y. H.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2019, 78 (05): : 467 - 473
  • [36] EFFICACY AND SAFETY OF REMISSION-INDUCTION/MAINTENANCE THERAPY IN 67 CASES OF NEW-ONSET ANCA-ASSOCIATED VASCULITIS
    Ota, Yuichiro
    Suzuki, Katsuya
    Takeuchi, Tsutomu
    RHEUMATOLOGY, 2017, 56 : 155 - 155
  • [37] Comparing the efficacy of low-dose vs high-dose cyclophosphamide regimen as induction therapy in the treatment of proliferative lupus nephritis: a single center study
    Sonal Mehra
    Jignesh B. Usdadiya
    Vikramraj K. Jain
    Durga Prasanna Misra
    Vir Singh Negi
    Rheumatology International, 2018, 38 : 557 - 568
  • [38] Efficacy and safety of low-dose rituximab as induction therapy for antineutrophil cytoplasmic antibody-associated vasculitis with renal involvement: a Chinese case series
    Lin Liu
    Haitao Lu
    Guming Zou
    Haifeng Wang
    Jing Li
    Yue Yang
    Jian Zhang
    Xueling Wang
    Wenge Li
    Li Zhuo
    BMC Nephrology, 24
  • [39] Efficacy and safety of low-dose rituximab as induction therapy for antineutrophil cytoplasmic antibody-associated vasculitis with renal involvement: a Chinese case series
    Liu, Lin
    Lu, Haitao
    Zou, Guming
    Wang, Haifeng
    Li, Jing
    Yang, Yue
    Zhang, Jian
    Wang, Xueling
    Li, Wenge
    Zhuo, Li
    BMC NEPHROLOGY, 2023, 24 (01)
  • [40] Comparing the efficacy of low-dose vs high-dose cyclophosphamide regimen as induction therapy in the treatment of proliferative lupus nephritis: a single center study
    Mehra, Sonal
    Usdadiya, Jignesh B.
    Jain, Vikramraj K.
    Misra, Durga Prasanna
    Negi, Vir Singh
    RHEUMATOLOGY INTERNATIONAL, 2018, 38 (04) : 557 - 568
12345